The Hidden Costs of Mismanaged R&D Projects in Biotech and Pharma
Mismanagement of R&D projects in biotech and pharma is more common than one might think…
19/04/2021 - 7 minutes
Interview
Changing Attitudes on Vaccine and Public Health Investment
The Covid-19 pandemic has pushed investment and research into vaccines and public health, but will…
21/04/2021 - 5 minutes
Trends & News
Vazkepa Gets EMA Nod for Cardiovascular Disease, But Hurdles Remain
Last month’s EU approval of Vazkepa -- a treatment derived from fish oil and branded…
- 5 minutes
Trends & News
Pandemic Boosts Diagnostics Field with High Revenues and Acquisitions
The US medtech firm Hologic has bought the Finnish-French biotech Mobidiag for around €668M in…
20/04/2021 - 5 minutes
What's New
MoreAchilles Therapeutics’ IPO Caps Investment Wave for Neoantigens
The close of the UK firm Achilles Therapeutics’ €146.9M ($175.5M) initial public offering last month…
15/04/2021 - 5 minutes
DBV Battles Aimmune for Share of Peanut Allergy Treatment Market
Last year, the FDA rejected DBV Technologies’ peanut allergy treatment and approved that of its…
14/04/2021 - 5 minutes
Biomaterials Are Making the Building Industry More Sustainable
There is a growing awareness of the waste and pollution caused by the building industry.…
14/04/2021 - 10 minutes
Eight Diseases CRISPR Technology Could Cure
CRISPR technology offers the promise to cure any human genetic disease with gene editing; which…
13/04/2021 - 9 minutes
Artios-Novartis Pact Pushes Limits of DNA Repair in Cancer
A €1.1B deal struck this week between Novartis and the UK-based company Artios Pharma forges…
08/04/2021 - 5 minutes
From Our Partners
View More
Sponsored
by PSI CRO
How to Ensure Clinical Trial Success in Asia and Europe
Sponsored
by GenScript
On Our Way to Covid-19 Immunity
Sponsored
by LINK Medical
Data Management: Taking the Right Turn at the Clinical Trial Crossroads
Sponsored
by MaxWell Biosystems
Can This New Electrophysiology Technology Boost Neurology Research?
Download our industry reports
View all our reports
